Pinnacle Associates
IDXX icon

Pinnacle Associates’s Idexx Laboratories IDXX Stock Holding History

Pinnacle Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$554K Sell
1,061
-28
-3% -$15.3K 0.01% 654
2026
Q2 		$573K Sell
1,089
-137
-11% -$76.8K 0.01% 660
2026
Q1 		$689K Sell
1,226
-1
-0.1% -$641 0.01% 593
2025
Q4 		$830K Buy
1,227
+18
+1% +$12.3K 0.01% 554
2025
Q3 		$772K Buy
1,209
+28
+2% +$17K 0.01% 555
2025
Q2 		$633K Sell
1,181
-330
-22% -$158K 0.01% 586
2025
Q1 		$635K Sell
1,511
-180
-11% -$78.2K 0.01% 568
2024
Q4 		$699K Sell
1,691
-379
-18% -$166K 0.01% 540
2024
Q3 		$1.15M Buy
2,070
+171
+9% +$83.1K 0.02% 447
2024
Q2 		$925K Buy
1,899
+11
+0.6% +$5.52K 0.01% 483
2024
Q1 		$1.02M Sell
1,888
-182
-9% -$99.5K 0.02% 476
2023
Q4 		$1.15M Sell
2,070
-18
-0.9% -$8.45K 0.02% 454
2023
Q3 		$913K Buy
2,088
+12
+0.6% +$5.98K 0.02% 473
2023
Q2 		$1.04M Buy
+2,076
New +$995K 0.02% 461

Other funds holding IDXX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
AustralianSuper
AustralianSuper Melbourne, Australia $24.4B AUM 44.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pinnacle Associates's IDXX Position: Q3 2026 in Review

Pinnacle Associates reduced its Idexx Laboratories (IDXX) stake by 2.6% in Q3 2026, selling an estimated $15.3K and leaving 1,061 shares worth $554K. The position accounts for 0.01% of the portfolio, ranked #654.

Pinnacle Associates first reported a position in IDXX in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.15M in Q3 2024. 804 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Pinnacle Associates held 1,061 shares of Idexx Laboratories worth $554K as of Q3 2026.
  • Pinnacle Associates sold 28 Idexx Laboratories shares in Q3 2026, an estimated $15.3K.
  • Idexx Laboratories made up 0.01% of Pinnacle Associates's portfolio in Q3 2026, its #654 holding.
  • Pinnacle Associates first reported a position in Idexx Laboratories in Q2 2023 and has held it in 14 quarters since.
  • Pinnacle Associates's Idexx Laboratories position peaked at $1.15M in Q3 2024.
  • 804 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.